Zai Lab Limited operates as a bio-pharmaceutical company. The Company researches and develops therapeutic technology for antibody-based oncology, autoimmune, and infectious diseases treatments. Zai Lab also manufactures drugs in the form of capsules, injections, and liquids. Zai Lab serves patients worldwide.

Annual Report to Security Holders (Form ARS | Period ending 2024-12-31)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Zai Lab Ltd (ZLAB US)

Annual Report to Security Holders (Form ARS | Period ending 2024-12-31)

Current Report (Form 8-K | Period ending 2025-01-02)

Current Report (Form 8-K | Period ending 2024-11-14)

424B5 | Prospectus

424B5 | Prospectus

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)